Skip to main content

Government Regulation of Drug Pricing and the Evolving Pharmaceutical Supply Chain

Theresa Carnegie discusses both federal and state activity regarding the regulation of drug pricing and how new entrants to the market, among other factors, are changing traditional pharmaceutical supply chain industry paradigms.

Subscribe To Viewpoints

Author

Theresa C. Carnegie is a Mintz attorney who advises health care clients on a wide array of transactional, regulatory, compliance, fraud and abuse matters, and health law issues. She counsels health plans, pharmacy benefit managers, pharmacies, device manufacturers, and distributors.